Filifactor alocis brain abscess identified by 16S ribosomal RNA gene sequencing: A case report.


Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 19 06 2019
revised: 16 08 2019
accepted: 24 09 2019
pubmed: 13 11 2019
medline: 12 9 2020
entrez: 13 11 2019
Statut: ppublish

Résumé

We report a clinical case of Filifactor alocis brain abscess in an 85-year-old man who had decayed teeth 1 week prior. In this case, the abscess was surgically drained after empirical antibiotics had been initiated. Although the causative organism could not be identified by culture, F. alocis was detected via 16S ribosomal RNA (16S rRNA) gene sequencing of the pus isolated from the abscess. The patient recovered without serious sequelae after surgical drainage and prolonged antibiotic treatment, including metronidazole, ceftriaxone and meropenem for 8 weeks. The findings in this case emphasize that 16S rRNA gene sequencing allows bacterial diagnosis of brain abscess when phenotypic identification fails, such as in cases where patients are undergoing antimicrobial treatment at the time of sampling or where patients are infected with fastidious organisms.

Identifiants

pubmed: 31711830
pii: S1341-321X(19)30292-2
doi: 10.1016/j.jiac.2019.09.013
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
RNA, Bacterial 0
RNA, Ribosomal, 16S 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

305-307

Informations de copyright

Copyright © 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Naokuni Hishiya (N)

Department of Infectious Diseases, Minami Nara General Medical Center, Nara, Japan. Electronic address: hishiya@naramed-u.ac.jp.

Kenji Uno (K)

Department of Infectious Diseases, Minami Nara General Medical Center, Nara, Japan.

Masayuki Amano (M)

Department of General Medicine, Minami Nara General Medical Center, Nara, Japan.

Kiyokazu Asada (K)

Department of Neurosurgery, Minami Nara General Medical Center, Nara, Japan.

Katsuya Masui (K)

Department of Neurosurgery, Minami Nara General Medical Center, Nara, Japan.

Yasuhito Ishida (Y)

Department of Neurosurgery, Minami Nara General Medical Center, Nara, Japan.

Yuki Suzuki (Y)

Department of Microbiology and Infectious Diseases, Nara Medical University, Nara, Japan.

Nobuyasu Hirai (N)

Center for Infectious Diseases, Nara Medical University, Nara, Japan.

Akiyo Nakano (A)

Department of Microbiology and Infectious Diseases, Nara Medical University, Nara, Japan.

Ryuichi Nakano (R)

Department of Microbiology and Infectious Diseases, Nara Medical University, Nara, Japan.

Kei Kasahara (K)

Center for Infectious Diseases, Nara Medical University, Nara, Japan.

Hisakazu Yano (H)

Department of Microbiology and Infectious Diseases, Nara Medical University, Nara, Japan.

Keiichi Mikasa (K)

Center for Infectious Diseases, Nara Medical University, Nara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH